The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
Laura C Lazzeroni - One of the best experts on this subject based on the ideXlab platform.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy. Methods Birth outcome was determined in the offspring of 55 women with major depressive disorder who used SSRI medication for different durations during their pregnancies. At an average age of 14 months, children underwent a pediatric examination and an evaluation with the Bayley Scales of Infant Development (BSID-II). Results Duration of in utero exposure to SSRIs was negatively associated with total Apgar scores, specifically the activity subscale. Odds ratios for a low score (<2) onthisscale were 3.8 and 6.0 at 1 and 5 min, respectively. Newborns with longer exposure were more often admitted to the Neonatal Intensive Care Unit (p<.03). Mental Development Index scores of the infants were not associated with the length of gestational exposure to SSRIs. A longer duration of exposure increased the risk for lower Psychomotor Developmental Index and Behavioral Rating Scale scores in infancy (p=0.012 andp=0.007, respectively) on the BSID-II. Conclusions The findings provide evidence that the length of prenatal SSRI antidepressant use can affect neonatal adjustment and can have an effect on Psychomotor test scores in infancy. Importantly, the children’ sm ental Development and motor function by neurological examination were within the normal range. Timing of exposure to SSRIs during susceptible periods of fetal Development and variations in the severity of maternal depression may have contributed to the associations.
Regina C Casper - One of the best experts on this subject based on the ideXlab platform.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy. Methods Birth outcome was determined in the offspring of 55 women with major depressive disorder who used SSRI medication for different durations during their pregnancies. At an average age of 14 months, children underwent a pediatric examination and an evaluation with the Bayley Scales of Infant Development (BSID-II). Results Duration of in utero exposure to SSRIs was negatively associated with total Apgar scores, specifically the activity subscale. Odds ratios for a low score (<2) onthisscale were 3.8 and 6.0 at 1 and 5 min, respectively. Newborns with longer exposure were more often admitted to the Neonatal Intensive Care Unit (p<.03). Mental Development Index scores of the infants were not associated with the length of gestational exposure to SSRIs. A longer duration of exposure increased the risk for lower Psychomotor Developmental Index and Behavioral Rating Scale scores in infancy (p=0.012 andp=0.007, respectively) on the BSID-II. Conclusions The findings provide evidence that the length of prenatal SSRI antidepressant use can affect neonatal adjustment and can have an effect on Psychomotor test scores in infancy. Importantly, the children’ sm ental Development and motor function by neurological examination were within the normal range. Timing of exposure to SSRIs during susceptible periods of fetal Development and variations in the severity of maternal depression may have contributed to the associations.
Barry E. Fleisher - One of the best experts on this subject based on the ideXlab platform.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy. Methods Birth outcome was determined in the offspring of 55 women with major depressive disorder who used SSRI medication for different durations during their pregnancies. At an average age of 14 months, children underwent a pediatric examination and an evaluation with the Bayley Scales of Infant Development (BSID-II). Results Duration of in utero exposure to SSRIs was negatively associated with total Apgar scores, specifically the activity subscale. Odds ratios for a low score (<2) onthisscale were 3.8 and 6.0 at 1 and 5 min, respectively. Newborns with longer exposure were more often admitted to the Neonatal Intensive Care Unit (p<.03). Mental Development Index scores of the infants were not associated with the length of gestational exposure to SSRIs. A longer duration of exposure increased the risk for lower Psychomotor Developmental Index and Behavioral Rating Scale scores in infancy (p=0.012 andp=0.007, respectively) on the BSID-II. Conclusions The findings provide evidence that the length of prenatal SSRI antidepressant use can affect neonatal adjustment and can have an effect on Psychomotor test scores in infancy. Importantly, the children’ sm ental Development and motor function by neurological examination were within the normal range. Timing of exposure to SSRIs during susceptible periods of fetal Development and variations in the severity of maternal depression may have contributed to the associations.
Joan Baran - One of the best experts on this subject based on the ideXlab platform.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy. Methods Birth outcome was determined in the offspring of 55 women with major depressive disorder who used SSRI medication for different durations during their pregnancies. At an average age of 14 months, children underwent a pediatric examination and an evaluation with the Bayley Scales of Infant Development (BSID-II). Results Duration of in utero exposure to SSRIs was negatively associated with total Apgar scores, specifically the activity subscale. Odds ratios for a low score (<2) onthisscale were 3.8 and 6.0 at 1 and 5 min, respectively. Newborns with longer exposure were more often admitted to the Neonatal Intensive Care Unit (p<.03). Mental Development Index scores of the infants were not associated with the length of gestational exposure to SSRIs. A longer duration of exposure increased the risk for lower Psychomotor Developmental Index and Behavioral Rating Scale scores in infancy (p=0.012 andp=0.007, respectively) on the BSID-II. Conclusions The findings provide evidence that the length of prenatal SSRI antidepressant use can affect neonatal adjustment and can have an effect on Psychomotor test scores in infancy. Importantly, the children’ sm ental Development and motor function by neurological examination were within the normal range. Timing of exposure to SSRIs during susceptible periods of fetal Development and variations in the severity of maternal depression may have contributed to the associations.
Allyson Gilles - One of the best experts on this subject based on the ideXlab platform.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy.
-
length of prenatal exposure to selective serotonin reuptake inhibitor ssri antidepressants effects on neonatal adaptation and Psychomotor Development
Psychopharmacology, 2011Co-Authors: Regina C Casper, Allyson Gilles, Joan Baran, Barry E. Fleisher, Gregory M Enns, Laura C LazzeroniAbstract:Objectives This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and Psychomotor Development in infancy. Methods Birth outcome was determined in the offspring of 55 women with major depressive disorder who used SSRI medication for different durations during their pregnancies. At an average age of 14 months, children underwent a pediatric examination and an evaluation with the Bayley Scales of Infant Development (BSID-II). Results Duration of in utero exposure to SSRIs was negatively associated with total Apgar scores, specifically the activity subscale. Odds ratios for a low score (<2) onthisscale were 3.8 and 6.0 at 1 and 5 min, respectively. Newborns with longer exposure were more often admitted to the Neonatal Intensive Care Unit (p<.03). Mental Development Index scores of the infants were not associated with the length of gestational exposure to SSRIs. A longer duration of exposure increased the risk for lower Psychomotor Developmental Index and Behavioral Rating Scale scores in infancy (p=0.012 andp=0.007, respectively) on the BSID-II. Conclusions The findings provide evidence that the length of prenatal SSRI antidepressant use can affect neonatal adjustment and can have an effect on Psychomotor test scores in infancy. Importantly, the children’ sm ental Development and motor function by neurological examination were within the normal range. Timing of exposure to SSRIs during susceptible periods of fetal Development and variations in the severity of maternal depression may have contributed to the associations.
